Abnormal amyloid PET usually represents intermediate/high Alzheimer's disease neuropathologic change

INTRODUCTION: Alzheimer's disease neuropathologic change (ADNC) classification identifies not/low and intermediate/high levels of neuropathology. Our goal was to assess how frequently a positive amyloid positron emission tomography (PET) scan indicates not/low ADNC and whether this autopsy finding can occur >10 years after a positive amyloid PET. METHODS: Participants with positive amyloid PET scans were categorized by levels of ADNC at autopsy, grouped by time from initial positive amyloid PET to time of death (<5 years, 5 to <10 years, or 10+ years). RESULTS: Among those with a positive amyloid PET scan, the majority had intermediate/high ADNC at autopsy (234/259, 90%). In the group with 10+ years between a positive amyloid PET and death (n = 39) not/low ADNC occurred in 3/39 (8%). DISCUSSION: Not/low ADNC is uncommon among those with positive amyloid PET scans. After 10+ years, it is possible but rare for a positive amyloid PET scan to represent an indolent state of neuropathology.

Authors

Institutions

Publication Details

Journal
Alzheimer s & Dementia
Published
2026-05-01
DOI
https://doi.org/10.1002/alz.71449
Primary Topic
Dementia and Cognitive Impairment Research
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Abnormal amyloid PET usually represents intermediate/high Alzheimer's disease neuropathologic change

D H Johnson, Aivi T. Nguyen, Miller MD, Heather J. Wiste et al.
Alzheimer s & Dementia
Dementia and Cognitive Impairment Research
article

Abnormal amyloid PET usually represents intermediate/high Alzheimer's disease neuropathologic change

D H Johnson, Aivi T. Nguyen, Miller MD, Heather J. Wiste, Petrice M. Cogswell, Ronald C. Petersen, Melissa E. Murray, Bradley F. Boeve, Clifford R. Jack, Jay Pillai, Kejal Kantarci, Christopher G. Schwarz, Val Lowe, Prashanthi Vemuri, David S. Knopman, Jonathan Graff‐Radford, Dennis W. Dickson
article en

Abstract

INTRODUCTION: Alzheimer's disease neuropathologic change (ADNC) classification identifies not/low and intermediate/high levels of neuropathology. Our goal was to assess how frequently a positive amyloid positron emission tomography (PET) scan indicates not/low ADNC and whether this autopsy finding can occur >10 years after a positive amyloid PET. METHODS: Participants with positive amyloid PET scans were categorized by levels of ADNC at autopsy, grouped by time from initial positive amyloid PET to time of death (<5 years, 5 to <10 years, or 10+ years). RESULTS: Among those with a positive amyloid PET scan, the majority had intermediate/high ADNC at autopsy (234/259, 90%). In the group with 10+ years between a positive amyloid PET and death (n = 39) not/low ADNC occurred in 3/39 (8%). DISCUSSION: Not/low ADNC is uncommon among those with positive amyloid PET scans. After 10+ years, it is possible but rare for a positive amyloid PET scan to represent an indolent state of neuropathology.

Alzheimer s & DementiaVol. 22(5)
Mayo Clinic (US), Jacksonville College (US), Mayo Clinic in Florida (US)
Foundation for the National Institutes of Health, GHR Foundation
Good health and well-being
Openalex Percentile: Top 7%
Dementia and Cognitive Impairment Research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.